Procter & Gamble (PG)
(Delayed Data from NYSE)
$165.76 USD
+0.68 (0.41%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $166.27 +0.51 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$165.76 USD
+0.68 (0.41%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $166.27 +0.51 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Is Most-Watched Stock Procter & Gamble Company (The) (PG) Worth Betting on Now?
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble (PG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
PG Stock Stays Flat After Q1 Earnings: Time to Reassess Your Position?
by Rajani Lohia
Procter & Gamble's Q1 results reflect further revenue slowdown on soft trends across key markets, while productivity actions support the bottom line.
PG Q1 Earnings Beat on Improved Margins, Sales Miss Estimates
by Zacks Equity Research
Procter & Gamble's Q1 results reflect gains from improved pricing, offset by adverse currency adverse currency rates and other impacts.
A Mixed Bag on Mixed Stock Market Data (revised)
by Mark Vickery
Also, will the Fed be forced to stop cutting interest rates this year?
Mixed Housing Market Data for September
by Zacks Equity Research
Mixed Housing Market Data for September.
A Mixed Bag on Mixed Stock Market Data
by Mark Vickery
Also, will the Fed be forced to stop cutting interest rates this year?
P&G (PG) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 1.58% and 0.88%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
Unlocking Q1 Potential of P&G (PG): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for P&G (PG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Procter & Gamble (PG) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $172.51, moving +0.83% from the previous trading session.
Pre-Q1 Earnings: To Buy or Not to Buy Procter & Gamble Stock?
by Rajani Lohia
Gains from strong pricing, cost-saving and productivity measures should aid PG in Q1 amid Greater China issues, geopolitical tensions and currency volatility.
Q3 Earnings Results of U.S. Corporate Giants in Focus
by Zacks Equity Research
Q3 Earnings Results of U.S. Corporate Giants in Focus.
Bank Holiday Ahead of Busy Stock Trading Week
by Mark Vickery
Despite today's day off from econ metrics, we see a pretty busy week ahead.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Investors Consider High Yield Dividend Stocks?
by Derek Lewis
When selecting dividend-paying stocks, one of the first things that investors look at is, of course, the annual yield. But is high yield always the way to go?
Procter & Gamble (PG) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $168.16, representing a +0.62% change from its previous close.
Procter & Gamble (PG) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the closing of the recent trading day, Procter & Gamble (PG) stood at $167.12, denoting a -1.04% change from the preceding trading day.
The Zacks Analyst Blog Highlights Exxon Mobil, Mastercard, Procter & Gamble and Vaso
by Zacks Equity Research
Exxon Mobil, Mastercard, Procter & Gamble and Vaso are included in this Analyst Blog.